Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 18, 2025, Nektar Therapeutics (NKTR) has a market cap of $0.12 billion USD. According to our data, Nektar Therapeutics is ranked No.7442 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 18, 2025 | $0.12 B |
-30.96%
|
| Dec 31, 2024 | $0.17 B |
66.07%
|
| Dec 29, 2023 | $0.10 B |
-75.22%
|
| Dec 30, 2022 | $0.42 B |
-83.27%
|
| Dec 31, 2021 | $2.49 B |
-20.53%
|
| Dec 31, 2020 | $3.14 B |
-21.26%
|
| Dec 31, 2019 | $3.98 B |
-34.32%
|
| Dec 31, 2018 | $6.06 B |
-44.96%
|
| Dec 29, 2017 | $11.02 B |
386.72%
|
| Dec 30, 2016 | $2.26 B |
-27.18%
|
| Dec 31, 2015 | $3.11 B |
8.71%
|
| Dec 31, 2014 | $2.86 B |
36.56%
|
| Dec 31, 2013 | $2.09 B |
53.17%
|
| Dec 31, 2012 | $1.37 B |
32.32%
|
| Dec 30, 2011 | $1.03 B |
-56.42%
|
| Dec 31, 2010 | $2.37 B |
37.88%
|
| Dec 31, 2009 | $1.72 B |
67.63%
|
| Dec 31, 2008 | $1.03 B |
-17.14%
|
| Dec 31, 2007 | $1.24 B |
-55.88%
|
| Dec 29, 2006 | $2.81 B |
-7.59%
|
| Dec 30, 2005 | $3.04 B |
-18.68%
|
| Dec 31, 2004 | $3.73 B |
48.71%
|
| Dec 31, 2003 | $2.51 B |
68.44%
|
| Dec 31, 2002 | $1.49 B |
-56.44%
|
| Dec 31, 2001 | $3.42 B |
-63.27%
|
| Dec 29, 2000 | $9.32 B |
137.30%
|
| Dec 31, 1999 | $3.93 B |
28.98%
|
| Dec 31, 1998 | $3.04 B |
26.92%
|
| Dec 31, 1997 | $2.40 B |
71.90%
|
| Dec 31, 1996 | $1.39 B |
55.13%
|
| Dec 29, 1995 | $0.90 B |
5.41%
|
| Dec 30, 1994 | $0.85 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Biogen
BIIB
|
$17.36 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
UK
|
| Market Cap | = | NKTR Stock Price | * | NKTR Shares Outstanding |
| = | $0.64 | * | 0.19 B | |
| = | $0.12 B |